2025年12月22日, Quantum BioPharma股份上升18%, 尽管集体诉讼指控银行操纵股票。 Quantum BioPharma shares jumped 18% on December 22, 2025, despite a class action lawsuit alleging bank stock manipulation.

2025年12月22日,尽管新提起集体诉讼,指控加拿大银行CIBC和RBC在2021年1月至10月期间操纵股票,但Quantum生物制药公司(QNTM)的股份在2025年12月22日猛增18%,达到10.52美元。 Quantum BioPharma Inc. (QNTM) shares surged 18% to $10.52 on December 22, 2025, despite a newly filed class action lawsuit alleging that Canadian banks CIBC and RBC engaged in stock manipulation from January 2021 to October 2025. 该诉讼案由股东Paul Durkacz和律师事务所Grant & Eisenhofer提出,声称银行使用欺骗手段人为压低股票价格。 The lawsuit, brought by shareholder Paul Durkacz and law firm Grant & Eisenhofer, claims the banks used spoofing tactics to artificially depress the stock price. 该公司开发神经降解和新陈代谢紊乱的治疗方法,包括Lucid-MS,也拥有Unbuzzd Wellness的股份,并从其产品中赚取特许权使用费。 The company, which develops treatments for neurodegenerative and metabolic disorders, including Lucid-MS, also owns a stake in Unbuzzd Wellness and earns royalties from its product unbuzzd™. 交易量猛增到33万股,远远高于平均水平,因为随着法律的发展,投资者的利息增加了。 Trading volume spiked to 330,000 shares, far above average, as investor interest grew amid the legal developments.